Table 1.
Demographics and clinical characteristics of study subjects.
| Characteristics | LGG (grade I–II) |
HGG (grade III–IV) |
Healthy Control | Total |
|---|---|---|---|---|
| No. of Subjects (n) | 4 + 5 = 9 | 1 + 16 = 17 | 16 | 42 |
| Mean Age (Years) | 33 ± 17 | 43 ± 16 | 34 ± 13 | 38 ± 16 |
| Gender | ||||
| Male | 07 | 11 | 07 | 25 |
| Female | 02 | 06 | 09 | 17 |
| Headache | ||||
| Yes | 05 | 13 | 0 | 18 |
| No | 04 | 04 | 16 | 24 |
| Epileptic Seizures | ||||
| Yes | 03 | 07 | 0 | 10 |
| No | 06 | 10 | 16 | 32 |
| Gait/Balance Changes | ||||
| Yes | 05 | 13 | 0 | 18 |
| No | 04 | 04 | 16 | 24 |
| Neurologic Deficits | ||||
| Yes | 07 | 15 | 0 | 22 |
| No | 02 | 02 | 16 | 20 |
| Reduced Vision | ||||
| Yes | 03 | 08 | 0 | 11 |
| No | 06 | 09 | 16 | 31 |
| Cancer History | ||||
| Yes | 01 | 03 | 0 | 04 |
| No | 08 | 14 | 16 | 38 |